Detalhe da pesquisa
1.
Predictors of significant fibrosis in chronic hepatitis B patients with low viremia.
J Clin Gastroenterol
; 48(6): e50-6, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24072073
2.
SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024.
Saudi J Gastroenterol
; 30(Supp 1): S1-S42, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38167232
3.
The natural history and long-term outcomes in patients with chronic hepatitis C genotype 4 after interferon-based therapy.
Liver Int
; 33(6): 871-83, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23490034
4.
A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia.
J Infect Public Health
; 13(11): 1715-1723, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32988769
5.
Greater prevalence of comorbidities with increasing age: Cross-sectional analysis of chronic hepatitis B patients in Saudi Arabia.
Saudi J Gastroenterol
; 25(3): 194-200, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30720002
6.
SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection.
Saudi J Gastroenterol
; 21(2): 60-3, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25843190
7.
SASLT practice guidelines for the management of hepatitis C virus infection: summary of recommendations.
Saudi J Gastroenterol
; 18(5): 293-8, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23006455
8.
SASLT practice guidelines: management of hepatitis C virus infection.
Saudi J Gastroenterol
; 18 Suppl: S1-32, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23006491